These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23342768)
21. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies. Hiniker A; Daniels BH; Lee HS; Margeta M Acta Neuropathol Commun; 2013 Jul; 1():29. PubMed ID: 24252466 [TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of inclusion body myositis. Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316 [TBL] [Abstract][Full Text] [Related]
24. Inclusion-body myositis presenting with facial diplegia. Ghosh PS; Laughlin RS; Engel AG Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039 [TBL] [Abstract][Full Text] [Related]
25. [Sporadic inclusion body myositis and amyloid]. Aoki M; Suzuki N Brain Nerve; 2014 Jul; 66(7):739-48. PubMed ID: 24998819 [TBL] [Abstract][Full Text] [Related]
26. Inclusion body myositis in the rheumatology clinic. Balakrishnan A; Aggarwal R; Agarwal V; Gupta L Int J Rheum Dis; 2020 Aug; 23(9):1126-1135. PubMed ID: 32662192 [TBL] [Abstract][Full Text] [Related]
27. Inclusion body myositis: old and new concepts. Amato AA; Barohn RJ J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1186-93. PubMed ID: 19864656 [TBL] [Abstract][Full Text] [Related]
28. ['Inclusion body'-myositis]. Badrising UA; Maat-Schieman ML; van Duinen SG; van Dijk JG; Verschuuren JJ; Wintzen AR Ned Tijdschr Geneeskd; 1998 Mar; 142(11):553-7. PubMed ID: 9623110 [TBL] [Abstract][Full Text] [Related]
29. Inclusion body myositis: a case of bilateral extremity weakness. Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075 [TBL] [Abstract][Full Text] [Related]
30. [Diagnostic muscle MRI abnormality in a patient with inclusion body myositis]. Ono K; Takizawa Y; Komai K; Nitta E; Takamori M Rinsho Shinkeigaku; 1998 May; 38(5):468-70. PubMed ID: 9805998 [TBL] [Abstract][Full Text] [Related]
34. [Inclusion body myositis]. Suzuki N; Aoki M Brain Nerve; 2011 Nov; 63(11):1205-15. PubMed ID: 22068473 [TBL] [Abstract][Full Text] [Related]
35. [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection]. Warabi Y; Matsubara S; Mizutani T; Hayashi H Rinsho Shinkeigaku; 2004 Sep; 44(9):609-14. PubMed ID: 15515704 [TBL] [Abstract][Full Text] [Related]
37. [Histological data in inflammatory myositis]. Mikol J; Polivka M Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088 [TBL] [Abstract][Full Text] [Related]
38. Polymyositis: not a unicorn or mythological beast...but maybe a duck? Kissel JT Neurology; 2008 Feb; 70(6):414-5. PubMed ID: 18250286 [No Abstract] [Full Text] [Related]
39. Inclusion Body Myositis. Goyal NA Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974 [TBL] [Abstract][Full Text] [Related]
40. Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives. Schmidt J; Dalakas MC Expert Rev Clin Immunol; 2013 Nov; 9(11):1125-33. PubMed ID: 24138579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]